rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Integer Holdings Corporation

ITGR · NYSE

Health CareMedical DevicesLeading

ITGR stood above a rising 150-day average in 19 of the last 52 weekly readings, including each of the last 19 weeks. It is 22.9% above that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Leading
Weeks in an uptrend
19 in a row
Industry in uptrend
27% -9 in 4 wk
Insider buys, 12 months
$500K
Insider sales, 12 months
$10.5M
Officials’ trades on record
0
Institutions holding
304 (+6)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 19 of 52 weeks.

17 Apr – 16 Oct
19%29%40%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$40.2M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months4
Sale orders, 12 months5
Buyers · sellers4 · 3
WhoDidSharesTraded
Kirk K. ThorChief Human Resources Officersold11,767at $126.2315 Sep 2026filed 16 Sep 2026
Kirk K. ThorChief Human Resources Officersold19,773at $126.2514 Sep 2026filed 16 Sep 2026
Andrew SennPresident, Growth & Innovationsold9,408at $126.308 Sep 2026filed 10 Sep 2026
Tommy P. ThomasVP, Corporate Controllersold825at $85.0013 Mar 2026filed 17 Mar 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders304+6 on the quarter
New · exited48 · 42
Reported value$3.7B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.added · filed 7 Aug 20265,353,741$500.3M+47,900+0.9%
Invesco Ltd.added · filed 14 Aug 20262,247,031$210.0M+277,898+14.1%
VANGUARD PORTFOLIO MANAGEMENT LLCreduced · filed 13 Aug 20262,040,469$190.7M-6,497−0.3%
DIMENSIONAL FUND ADVISORS LPadded · filed 11 Aug 20261,627,784$152.1M+143,388+9.7%
NOMURA HOLDINGS INCadded · filed 14 Aug 20261,554,450$145.3M+1,106,089+246.7%
VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 20261,531,843$143.2M-5,444−0.4%
STATE STREET CORPadded · filed 7 Aug 20261,413,174$132.0M+14,888+1.1%
MORGAN STANLEYreduced · filed 13 Aug 20261,345,748$125.8M-193,535−12.6%
Irenic Capital Management LPadded · filed 14 Aug 20261,264,259$118.1M+5960.0%
EARNEST PARTNERS LLCreduced · filed 13 Aug 20261,008,519$94.2M-32,629−3.1%
31 Mar 2023 – 30 Jun 2026
198259320Mar 23Dec 23Dec 24Sep 25Jun 26

Everyone who traded it

Kirk K. Thor Company insiderChief Human Resources Officer · last 15 Sep 20260 · 2
Andrew Senn Company insiderPresident, Growth & Innovation · last 8 Sep 20260 · 2
Milo Stephen Metcalf II Company insiderUS - EVP, Operations · last 6 Jul 20260 · 0
John A. Harris Company insiderPresident, Glob Ops & Manu Tec · last 29 Jun 20261 · 4
Aaron Kapito Company insiderDirector · last 20 May 20260 · 0
Alvin Tyrone Jeffers Company insiderDirector · last 20 May 20260 · 0
Cheryl C. Capps Company insiderDirector · last 20 May 20261 · 0
Donald J. Spence Company insiderDirector · last 20 May 20260 · 4
Filippo Passerini Company insiderDirector · last 20 May 20260 · 0
James F. Hinrichs Company insiderDirector · last 20 May 20261 · 1
James Francis Flanagan Company insiderDirector · last 20 May 20260 · 0
Martin C. Maxwell Company insiderDirector · last 20 May 20261 · 2

Same industry

RCEL Avita MedicalLeading+100%
ATRC AtriCureLeading+49%
HAE HaemoneticsLeading+48%
HTFL HeartflowLeading+40%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202527.0%
Operating profit marginFY 2025 · to 31 Dec 202511.9%
Free cash flow marginFY 2025 · to 31 Dec 20255.7%
Return on capital employedFY 2025 · to 31 Dec 20257.0%
Cash conversionFY 2025 · to 31 Dec 2025191%
Debt to equityFY 2025 · to 31 Dec 20250.68×
Share count trendFY 2025 · to 18 Feb 20260.2%
Cash and equivalentsFY 2025 · to 31 Dec 2025$17.2M
Free cash flowFY 2025 · to 31 Dec 2025$105.1M

Analyst forecasts

No analyst forecasts yet.